Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study

BACKGROUND: We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson’s disease (PD) and overactive bladder (OAB), refractory to antimuscarinics. MATERIALS AND METHODS: Thirty patients with PD and refractory OAB were prospectively included in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gubbiotti, Marilena, Conte, Antonella, Di Stasi, Savino M., Tambasco, Nicola, Giannantoni, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515844/
https://www.ncbi.nlm.nih.gov/pubmed/31156718
http://dx.doi.org/10.1177/1756286419843458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515844/
https://www.ncbi.nlm.nih.gov/pubmed/31156718
http://dx.doi.org/10.1177/1756286419843458

Ejemplares similares